423 related articles for article (PubMed ID: 21715702)
1. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of periodic leg movements from arousals in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Bassetti CL; Fulda S; Aricò D; Ferini-Strambi L
Ann Neurol; 2012 Jun; 71(6):834-44. PubMed ID: 22718547
[TBL] [Abstract][Full Text] [Related]
3. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.
Ferri R; Manconi M; Plazzi G; Bruni O; Cosentino FI; Ferini-Strambi L; Zucconi M
Sleep Med; 2012 May; 13(5):529-35. PubMed ID: 22341907
[TBL] [Abstract][Full Text] [Related]
4. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
5. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
7. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
[TBL] [Abstract][Full Text] [Related]
8. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
9. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Stiasny-Kolster K; Oertel WH
Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
[TBL] [Abstract][Full Text] [Related]
11. Defining the boundaries of the response of sleep leg movements to a single dose of dopamine agonist.
Manconi M; Ferri R; Feroah TR; Zucconi M; Ferini-Strambi L
Sleep; 2008 Sep; 31(9):1229-37. PubMed ID: 18788648
[TBL] [Abstract][Full Text] [Related]
12. Acute dopamine-agonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability.
Ferri R; Manconi M; Aricò D; Sagrada C; Zucconi M; Bruni O; Oldani A; Ferini-Strambi L
Sleep; 2010 Jun; 33(6):793-800. PubMed ID: 20550020
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
14. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
Montplaisir J; Denesle R; Petit D
Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
[TBL] [Abstract][Full Text] [Related]
15. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
Montplaisir J; Nicolas A; Denesle R; Gomez-Mancilla B
Neurology; 1999 Mar; 52(5):938-43. PubMed ID: 10102409
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.
Manconi M; Ferri R; Zucconi M; Clemens S; Rundo F; Oldani A; Ferini-Strambi L
Sleep Med; 2011 Jan; 12(1):47-55. PubMed ID: 20851046
[TBL] [Abstract][Full Text] [Related]
18. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
